vimarsana.com
Home
Live Updates
Emalex Biosciences Inc About - Breaking News
Pages:
Latest Breaking News On - Emalex biosciences inc about - Page 1 : vimarsana.com
Emalex Biosciences Publishes Phase 2b Results for Tourette Syndrome Candidate in Pediatrics
Study data shows investigational new drug, ecopipam, reduced total number of tics by 30% compared to placeboCHICAGO, Jan. 11, 2023 /PRNewswire/ .
United states
Donald gilbert
Sheridan chaney
Emalex biosciences
Emalex biosciences inc about ecopipam
Paragon biosciences
Yale global tourette severity total tic
Clinical global impression
Tourette syndrome severity
North america
Cincinnati children
Emalex biosciences inc about
Orphan drug
Fast track
About paragon biosciences
vimarsana © 2020. All Rights Reserved.